Allergan Posts 2nd-Quarter Loss; Contribution Blamed

Allergan Inc., an Irvine health care company, recorded a second-quarter loss of $23 million, or 36 cents a share, contrasted with a year-earlier profit of $23.5 million, or 37 cents a share. The company attributed the loss to the $50 million it contributed during the 1995 second quarter to Allergan-Ligand Retinoid Therapeutics Inc., a recently formed public company that replaced a joint venture. Sales increased 17% to $262.2 million from 224.7 million.

A net loss of $1.3 million, or 2 cents a share, was reported for the first half, contrasted with a year-earlier profit of $45.7 million, or 72 cents a share. Sales rose 13% to $490.5 million from $434.8 million.